N-acetylation pharmacogenetics.
Weber
W W
WW
Hein
D W
DW
D000070:Acebutolol / Q000378:metabolism; D000105:Acetyl Coenzyme A / Q000378:metabolism; D000107:Acetylation; D000123:Acetyltransferases / Q000378:metabolism; D000616:Aminoglutethimide / Q000378:metabolism; D000818:Animals; D014151:Anti-Anxiety Agents / Q000378:metabolism; D001569:Benzodiazepines; D002110:Caffeine / Q000378:metabolism; D002273:Carcinogens / Q000378:metabolism; D006224:Cricetinae; D003622:Dapsone / Q000378:metabolism; D004194:Disease / Q000378:metabolism; D064420:Drug-Related Side Effects and Adverse Reactions; D005006:Ethnicity; D005838:Genotype; D006801:Humans; D006834:Hydrazines / Q000378:metabolism; D007700:Kinetics; D008099:Liver / Q000201:enzymology; D051379:Mice; D008954:Models, Biological; D009153:Mutagens / Q000378:metabolism; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D010597:Pharmacogenetics; D010641:Phenotype; D011110:Polymorphism, Genetic; D011342:Procainamide / Q000378:metabolism; D011817:Rabbits; D013045:Species Specificity; D013379:Substrate Specificity; D012460:Sulfasalazine / Q000378:metabolism
D014151:Anti-Anxiety Agents; D002273:Carcinogens; D006834:Hydrazines; D009153:Mutagens; D004364:Pharmaceutical Preparations; D000616:Aminoglutethimide; D001569:Benzodiazepines; D002110:Caffeine; D012460:Sulfasalazine; D000070:Acebutolol; D000105:Acetyl Coenzyme A; D003622:Dapsone; D000123:Acetyltransferases; D011342:Procainamide